1)Whitemore WF:Hormone therapy in prostatic cancer. Am J Med 21:697-713, 1956
2)Jewett HJ:The present status of radical prostatectomy for stage A and B prostatic cancer. Urol Clin North Am 2:105-124, 1975
3)前立腺癌取扱い規約第4版,金原出版,東京,2010
4)古谷琢也,大山 力:前立腺癌の診断―臨床病期分類の意義と問題点.日本臨床69:310-213,2011
5)有馬公伸,林 宣男,柳川 眞,ほか:膀胱癌と前立腺癌の病期画像診断の進歩―Endorectal MRI and MTC.泌尿紀要45:553-557,1999
6)Girouin N, Mège-Lechevallier F, Tonina Senes A, et al:Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria:is it reasonable? Eur Radiol 17:1498-1509, 2007
7)Langer DL, van der Kwast TH, Evans AJ, et al:Intermixed normal tissue within prostate cancer:effect on MRI imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology 249:900-908, 2008
8)Hövels AM, Heesakkers RA, Adang EM, et al:The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:a meta-analysis. Clin Radiol 63:387-395, 2008
9)Husarik DB, Miralbell R, Dubs M, et al:Evaluation of[(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 35:253-263, 2008